⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABBV News
ABBVIE INC.
UT Health San Antonio research shows Alzheimer's prevention potential in pairing cannabis ingredient, anti-inflammatory drug
prnewswire.com
CGC
ABBV
PFE
Skin Boosters Market to Surpass USD 3,263.80 Million by 2032, Shows New Analysis on Injectable Skin Rejuvenation and Anti-Aging Trends: MMR Statistics
prnewswire.com
ABBV
Allergan Aesthetics Unveils New Data Across Facial Injectables On-Market and Emerging Portfolio at IMCAS 2026 Showcasing Enduring Strength in Advancing Aesthetics Medicine
prnewswire.com
ABBV
App Test Automation Industry Research 2026 - Global Market Size, Share, Trends, Opportunities, and Forecasts, 2021-2025 & 2026-2031
globenewswire.com
LOGI
MSFT
GOOG
AMZN
IBM
ORCL
INTC
NVDA
CRM
ADBE
SAP
EA
TTWO
ROKU
NFLX
DIS
CMCSA
TCOM
MELI
SHOP
PYPL
UBER
LYFT
DDOG
PANW
CRWD
ZS
NOW
TWLO
SNOW
PLTR
AI
STX
WDC
HPQ
DELL
HPE
QCOM
MRVL
AMD
MU
AMAT
LRCX
KLAC
ASML
GLW
AVGO
NXPI
TER
KEYS
NI
CHKP
FTNT
PPC
LULU
SIRI
BBY
TJX
LOW
HD
CAT
BA
GD
LMT
RTX
HON
GE
MMM
AXP
JPM
BAC
WFC
C
GS
MS
V
MA
PG
KO
PEP
MCD
SBUX
VZ
T
CHTR
TMUS
AMGN
BMY
PFE
JNJ
MRK
ABBV
LLY
GILD
BIIB
REGN
VRTX
AZN
SNY
NVS
XOM
CVX
SHEL
BABA
JD
NTES
PDD
EDU
TAL
BIDU
VIPS
CPRT
Atopic Dermatitis Market to Reach USD 12.97 Billion by 2034, Growing at 7.75% CAGR
globenewswire.com
REGN
LLY
AMGN
SNY
ABBV
INCY
GSK
PFG
DERM
Regenerative Medicine Market Review 2020-2024 and Forecast 2025-2033: A $578.29 Bn Opportunity Says Astute Analytica
globenewswire.com
VRTX
CRSP
TMO
ABBV
AMGN
NVS
BDX
The AbbVie Foundation Is Now Accepting Applications to Participate in the 2026 AbbVie Foundation Health Equity Accelerator
businesswire.com
ABBV
Publication of Crystal Structure of Ritonavir Form IV and Thermodynamic Relationships between Ritonavir Polymorphs
prnewswire.com
ABBV
RET Fusion Targeted Therapies Market Set for Robust Growth by 2034 Amid Precision Oncology Shift | DelveInsight
prnewswire.com
MRK
LLY
RIGL
AZN
GILD
ABBV
PFE
TMO
BMY
NVS
BIIB
CD137 Targeted Therapy Research Report 2026-2030: 90 Therapies in Clinical Trials, Upcoming Commercial Launches, Global & Regional Clinical & Commercial Trends,
globenewswire.com
GILD
BMY
REGN
MRK
PFE
ABBV
BIIB
AZN
AMGN
NVS
GMAB
ABL
BNTX